Bio-techne CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

22 Aug 2025

TECH

10-K: Bio-Techne Reports Mixed FY25 Results Amid Restructuring

Bio-Techne Corporation reported a 5% increase in net sales to $1.2 billion for fiscal year 2025, but GAAP net earnings decreased 56% due to non-recurring charges, while adjusted net earnings grew 8%.

NASDAQ

22 Aug 2024

TECH

Bio-techne CORP

10-K: Bio-Techne Corporation Reports Fiscal Year 2024 Results Amidst Strategic Shifts

Bio-Techne Corporation's fiscal year 2024 saw a modest revenue increase alongside a significant drop in net earnings, influenced by acquisitions, strategic investments, and restructuring efforts.